Subtopic Deep Dive
Global Governance of Regenerative Medicine
Research Guide
What is Global Governance of Regenerative Medicine?
Global Governance of Regenerative Medicine refers to international frameworks, standards, and policies coordinating oversight of stem cell therapies, organoids, and bioprinting to balance innovation, safety, and ethical concerns across jurisdictions.
Researchers analyze comparative policies in countries like Thailand (Pérez Velasco et al., 2013, 184 citations) and address stem cell tourism risks (Petersen et al., 2013, 104 citations). ISCT/ISSCT guidelines and WHO coordination aim for harmonized standards. Over 20 papers since 2006 map regulatory gaps in regenerative biotechnologies.
Why It Matters
Global governance prevents regulatory arbitrage where clinics exploit lax jurisdictions for unproven stem cell treatments, as seen in stem cell tourism (Petersen et al., 2013). Harmonized standards reduce patient risks from exploitative marketing (Murdoch et al., 2018) and support safe translation across the 'valley of death' (Meslin et al., 2013). Frameworks enable ethical bioprinting and organoid use (Vermeulen et al., 2017; Mollaki, 2021).
Key Research Challenges
Regulatory Arbitrage
Patients seek unproven stem cell treatments in countries with weak oversight, increasing risks (Petersen et al., 2013, 104 citations). Clinics market therapies via misleading websites (Murdoch et al., 2018, 64 citations). International harmonization lags behind innovation.
Translation Valley of Death
Biomedical advances in regenerative medicine fail to reach clinics due to policy gaps (Meslin et al., 2013, 79 citations). Ethical and regulatory hurdles block progress from bench to bedside. Coordinated global policies are needed.
Ethical Harmonization Gaps
Differing national views on germline editing and organoids complicate collaboration (Brokowski, 2018, 137 citations; Mollaki, 2021, 81 citations). Bioethics statements lack enforcement mechanisms. Parallel ethical research is proposed (Jongsma and Bredenoord, 2020).
Essential Papers
Advanced health biotechnologies in Thailand: redefining policy directions
Román Pérez Velasco, Usa Chaikledkaew, Chaw Myint et al. · 2013 · Journal of Translational Medicine · 184 citations
Do CRISPR Germline Ethics Statements Cut It?
Carolyn Brokowski · 2018 · The CRISPR Journal · 137 citations
The extraordinary wave of genomic-engineering innovation, driven by CRISPR-Cas9, has sparked worldwide scientific and ethical uncertainty. Great concern has arisen across the globe about whether he...
3D bioprint me: a socioethical view of bioprinting human organs and tissues
Niki Vermeulen, Gill Haddow, Tirion Seymour et al. · 2017 · Journal of Medical Ethics · 124 citations
In this article, we review the extant social science and ethical literature on three-dimensional (3D) bioprinting. 3D bioprinting has the potential to be a âgame-changerâ, printing human organs...
Therapeutic journeys: the hopeful travails of stem cell tourists
Alan Petersen, Kate Seear, Megan Munsie · 2013 · Sociology of Health & Illness · 104 citations
Abstract The recent growth of so‐called stem cell tourism reflects the high optimism that currently surrounds stem cell science. Stem cell treatments for various conditions are increasingly adverti...
Embryonic Economies: The Double Reproductive Value of Stem Cells
Sarah Franklin · 2006 · BioSocieties · 103 citations
Ethical Challenges in Organoid Use
Vasiliki Mollaki · 2021 · BioTech · 81 citations
Organoids hold great promises for numerous applications in biomedicine and biotechnology. Despite its potential in science, organoid technology poses complex ethical challenges that may hinder any ...
Mapping the translational science policy ‘valley of death’
Eric M. Meslin, Alessandro Blasimme, Anne Cambon‐Thomsen · 2013 · Clinical and Translational Medicine · 79 citations
Abstract Translating the knowledge from biomedical science into clinical applications that help patients has been compared to crossing a valley of death because of the many issues that separate the...
Reading Guide
Foundational Papers
Start with Petersen et al. (2013, 104 citations) for stem cell tourism risks; Pérez Velasco et al. (2013, 184 citations) for policy models; Franklin (2006, 103 citations) for stem cell economics; Meslin et al. (2013, 79 citations) for translation barriers.
Recent Advances
Study Brokowski (2018, 137 citations) on CRISPR ethics; Vermeulen et al. (2017, 124 citations) on bioprinting; Mollaki (2021, 81 citations) on organoids; Jongsma and Bredenoord (2020, 63 citations) on ethical guidance.
Core Methods
Comparative policy analysis (Pérez Velasco et al., 2013), clinic website audits (Murdoch et al., 2018), accreditation models (Snowden et al., 2017), and ethics parallel research (Jongsma and Bredenoord, 2020).
How PapersFlow Helps You Research Global Governance of Regenerative Medicine
Discover & Search
Research Agent uses searchPapers and exaSearch to find policy papers like 'Therapeutic journeys: the hopeful travails of stem cell tourists' (Petersen et al., 2013), then citationGraph reveals clusters on stem cell tourism and Thai biotech policy (Pérez Velasco et al., 2013), while findSimilarPapers uncovers related works on regulatory arbitrage.
Analyze & Verify
Analysis Agent applies readPaperContent to extract governance claims from Pérez Velasco et al. (2013), verifies them with verifyResponse (CoVe) against WHO guidelines, and uses runPythonAnalysis for citation trend stats via pandas on 10 key papers, with GRADE grading for evidence strength in policy recommendations.
Synthesize & Write
Synthesis Agent detects gaps in global standards across papers like Meslin et al. (2013) and Petersen et al. (2013), flags contradictions in ethical statements (Brokowski, 2018), then Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to produce a policy review manuscript with exportMermaid diagrams of regulatory flows.
Use Cases
"Analyze citation trends in stem cell tourism papers using Python."
Research Agent → searchPapers('stem cell tourism governance') → Analysis Agent → runPythonAnalysis(pandas plot of citations from Petersen et al. 2013 and Murdoch et al. 2018) → matplotlib trend graph exported as image.
"Draft LaTeX review on Thai regenerative medicine policy."
Research Agent → citationGraph(Pérez Velasco et al. 2013) → Synthesis Agent → gap detection → Writing Agent → latexEditText(structure review) → latexSyncCitations(10 papers) → latexCompile(PDF output with bibliography).
"Find code for simulating regulatory arbitrage models."
Research Agent → searchPapers('regenerative medicine policy models') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(extracts Python sim from policy papers) → runPythonAnalysis(verify model on Meslin et al. 2013 data).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on regenerative governance, chaining searchPapers → citationGraph → GRADE grading for a structured report on ISCT standards. DeepScan applies 7-step analysis with CoVe checkpoints to verify claims in Petersen et al. (2013) against global datasets. Theorizer generates policy harmonization theories from contradictions in Brokowski (2018) and Jongsma (2020).
Frequently Asked Questions
What defines global governance of regenerative medicine?
It encompasses international standards like ISCT/ISSCT guidelines and WHO coordination for stem cell, bioprinting, and organoid oversight to prevent regulatory gaps (Petersen et al., 2013).
What methods analyze governance challenges?
Comparative policy analysis (Pérez Velasco et al., 2013), website audits of clinics (Murdoch et al., 2018), and ethics parallel research (Jongsma and Bredenoord, 2020) map best practices.
What are key papers?
Top cited: Pérez Velasco et al. (2013, 184 citations) on Thai policy; Petersen et al. (2013, 104 citations) on stem cell tourism; Meslin et al. (2013, 79 citations) on translation gaps.
What open problems persist?
Harmonizing germline ethics (Brokowski, 2018), organoid regulations (Mollaki, 2021), and bridging the translational valley (Meslin et al., 2013) lack enforceable global mechanisms.
Research Biomedical Ethics and Regulation with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Global Governance of Regenerative Medicine with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Biomedical Ethics and Regulation Research Guide